AI-generated summary
This review summarizes randomized controlled trial evidence on repeated low-level red-light therapy for myopia control in children. The authors report that the therapy significantly reduced axial elongation and slowed myopic onset and progression, with network meta-analyses suggesting superior efficacy compared with established interventions. They note that short-term safety appears favorable, but uncertainties remain about some observed retinal structural and functional changes and about long-term safety.
- Who or what was studied
- children with myopia
- Limits stated in the abstract
- The abstract does not state the number of included studies or participants, and it notes unresolved uncertainties about clinical significance of retinal changes and the need for long-term monitoring.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Myopia, Repeated low-level red light, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.